anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The inclusion of biological control in the integrated management of rice blast (Magnaporthe oryzae [Mo]) reduces pesticide application. Phanerochaete australis (Pha) has been shown to be a potential inducer of resistance to rice blast. Pha was isolated saprophytically from the rice phylloplane and studied for its interaction with Mo in the defense process of upland rice plants against the pathogen attack. Investigating the Pha × Mo interaction in a completely randomized design, the suppression of leaf blast and the epidemiological components of disease development were quantified in vivo, whereas the physiological and biochemical aspects, as defense enzymes and oxidative complex components, were evaluated in vitro during the induction of resistance. In the Pha × Mo interaction, it was found that seed treatment can significantly reduce disease severity by up to 93%, increase the photosynthetic apparatus, mobilize photoassimilates to the defense system, intensify defense enzyme and oxidant complex activities (chitinase [CHI], β-1,3-glucanase [GLU], lipoxygenase [LOX], phenylalanine ammonia-lyase [PAL], poliphenoloxidase [PPO], peroxidase [POX], catalase [CAT], cuperoxide dismutase [SOD]), decrease phenolic compounds (TPCs), and increase photosynthetic pigment levels compared with the negative control (Mo). When treating the seed, we are referring to an induction process where there is no physical contact between the pathogens. The enzymes produced by the interaction between the microorganisms validate this process; thus, Pha acts as an inducer of resistance to upland rice plants challenged with Mo.
PURPOSE:To obtain an encapsulation body having superior water resistance, transparency and mechanical strength and suitable for optical use, use for a living body or use as agricultural chemicals by heating a clay material or mica having a lamellar structure in a hermetically sealed vessel to carry out encapsulation treatment. CONSTITUTION:A clay mineral or mica having a lamellar structure and a substance to be inclined are heated in a solvent in a hermetically sealed vessel to carry out encapsulation treatment. Natural montmorillonite, vermiculite or synthetic mica is preferably used as the clay material or mica. An org. dye such as a coumarin deriv., xanthin dye or oxazine dye or an inorg. substance such as KCl, AlCl3 or Pb(NO3)2 is used as the substance to be encapsulated in the clay mineral or mica. Any solvent such as water, alcohol or acetone may be used as the solvent and a proper solvent is selected according to the solubility of the substance to be encapsulated. The pref. encapsulation treatment temp. is 80-300 deg.C.
A tension-free trapezoidal flap will be elevated by the split-full-split technique. A 1-mm thick SCTG will be harvested from the palate as epithelialized graft. After epithelium removal, the graft was positioned and sutured 1mm apical to the cement-enamel junction with 5-0 resorbable sutures . The SCTG will then be covered by the tension-free coronally positioned flap by 5-0 silk sutures.After flap repositioning, two horizontal cross-mattress compressive sutures and one vertical cross-mattress compressive suture will be placed. All compressive sutures will be performed using 2.0 silk suture.
A bone marrow harvest (500 mL under general anaesthesia) is performed and BM-MNC are separated and concentrated (30mL). A placebo cell-product (30 mL saline with 4 ml peripheral blood) is implanted and the BM-MNC are cryo-conserved. Only the cell therapy unit, neither the patient, nor the clinician, know whether BM-MNC or placebo is implanted. After 6 months, it is possible to use previously cryo-conserved BM-MNC.
The invention discloses a polypeptide with dual functions of anti-inflammatory and antibacterial and application of the polypeptide to modification of self-assembled phospholipid micelle, wherein the polypeptide is an amphipathic cationic polypeptide R18, and the sequence of the polypeptide R18 is H2N-RWLRRWLRLWRRLWRLLR-CONH 2. Both R18 and M-CR18 can specifically target ligands of TLR2 and TLR4, inhibit activation of downstream signaling pathways and exert anti-inflammatory effects. R18 and M CR18 also exhibit good antibacterial activity. Through electrostatic interactions, R18 and M-CR18 can reverse bacterial membrane potential, induce bacterial membrane disruption, raise the ROS levels inside the bacteria, and cause bacterial death. The bacterial membrane is destroyed very fast, and the sterilizing effect can be achieved under the condition of not activating adaptive immunity. In addition, R18 and M-CR18 can inhibit bacterial biofilm formation, so it rarely develops drug resistance. Second, R18 and M-CR18 may also limit bacterial movement by inhibiting flagella synthesis, preventing further bacterial invasion. Therefore, the invention has great application prospect in treating acute lung injury, bacterial infection lung disease and sepsis.
Home-based pulmonary rehabilitation (HBPR) has been used in patients with chronic obstructive pulmonary disease, asthma and pulmonary fibrosis. Results from HBPR have been similar to those observe in the outpatient pulmonary rehabilitation such improvement in exercise capacity, symptoms and quality of life. However, HBPR has not yet been investigated in patients with bronchiectasis, a progressive and debilitating disease with a high socioeconomic impact. Objective: To investigate the short-and long-term effects of the home rehabilitation program in peripheral muscle strength, functional capacity and quality of life in patients with bronchiectasis. Methods: Patients diagnosed with bronchiectasis will be recruited from the Obstructive Diseases Outpatient Clinic of the Hospital das Clínicas - Medicine School, University of São Paulo. Participants will be randomized into two groups: control group (usual care and recommendations for performing exercises and respiratory physiotherapy) and training group, that will perform aerobic (stepping training) and resistance training (lower and upper limbs) for eight weeks, three times a week. All patients will receive a phone call once a week and patients allocated to the training group, additionally, will get a home visit every 15 days. At baseline, immediately after finishing and after six months of the HBPR patients will undergo to assessments. Expected results: HBPR will have positive effects on exercise tolerance and quality of life. Also, this study will contribute to future guidelines on the recommendation of HBPR for patients with bronchiectasis.
The invention discloses an oral medicinal preparation for treating vomit and a preparation method thereof. The preparation treats alizapride as main medicine and polyvinyl pyrrolidone, low molecular weight hydroxy propyl cellulose, polyethylene glycol 400, cation exchange resin, xylitol, FD&C blue food colorant 1 and FD&C red food colorant 40 as accessories. The preparation has the advantage that the prepared alizapride oral instant preparation can be rapidly dissolved in an oral cavity when meeting with saliva. The medicine can enter a systematic circulation through absorbed by gastrointestinal tract after being changed into a liquid, and has a good taste, and no coarse and bitter feeling. Compared with current alizapride tablets in the market, the film agent, the preparation of the present invention, has a more rapid dissolving speed and action effect, and provides convenience for rapidly alleviating the vomit symptom. A solution coating method employed in the invention is an initial production technology of the domestic pharmaceutical industry, and the produced medicine has the characteristics of stable quality, high production efficiency, low cost and broad market prospect.
Unintended pregnancy has multiple adverse effects on both maternal and child health. The United States continues to have one of the highest rates of unintended pregnancy among developed countries. To combat this problem, we are studying initiation of the highly effective intrauterine device (IUD) for women presenting for emergency contraception (EC). This is an ideal population to initiate highly effective reversible contraception (HERC) as they are at high risk of unintended pregnancy and are acting to reduce that risk. We have recently demonstrated significantly lower pregnancy rates 12 months after presenting for EC among women who selected the copper IUD versus those who selected oral Levonorgestrel (LNG).

Not only is the copper IUD the most effective method of EC, it is considered a top tier anticipatory contraception method and its ability to prevent pregnancy is on par with tubal sterilization (less than 1% in the first year with lower failure rates in subsequent years). However, women selecting intrauterine contraception have shown a strong preference for the LNG IUD. The LNG IUD, is as effective at preventing pregnancy as the Copper IUD, and has some non-contraceptive effects that many women see as benefits such as the reduction or elimination of menstrual bleeding and menstrual related discomfort. Of currently available reversible contraceptives, the LNG IUD has the highest levels of user satisfaction and continuation. However, its effectiveness as an emergency contraceptive remains unknown. A randomized control trial is necessary to assess the safety and efficacy of the LNG IUD as EC. Demonstrating the efficacy, safety, and acceptability of the LNG IUD for EC will improve options for women seeking EC and who desire a highly effective method of contraception.
Two-hundred and fifty-two women older than 70 years will be randomize to one of three groups. The first (exercise) will participate at an exercise program three times weekly for 90 minutes. The training will consist of an endurance and resistance training and will be carried out in a group. Participants in the second group (mental training) will take computer lessons, three times weekly for 90 minutes. Both interventions will be carried out for 26 weeks. Participants in the third group (control) will not participate at an structured intervention.
Despite advances in antimicrobial and anti-inflammatory treatment, inflammation and its consequences remain a major challenge in the field of medicine. Inflammatory reactions can lead to life-threatening conditions such as septic shock, while chronic inflammation has the potential to worsen the condition of body tissues and ultimately lead to significant impairment of their functionality. Although the central nervous system has long been considered immune privileged to peripheral immune responses, recent research has shown that strong immune responses in the periphery also affect the brain, leading to reactive microglia, which belong to the innate immune system and reside in the brain, and neuroinflammation. The inflammatory response is primarily a protective mechanism to defend against pathogens and tissue damage. However, excessive and chronic inflammation can have negative effects on neuronal structure and function. Neuroinflammation underlies the pathogenesis of many neurological and neurodegenerative diseases and can accelerate their progression. Consequently, targeting inflammatory signaling pathways offers potential therapeutic strategies for various neuropathological conditions, particularly Parkinson's and Alzheimer's disease, by curbing inflammation. Here the blood-brain barrier is a major hurdle for potential therapeutic strategies, therefore it would be highly advantageous to foster and utilize brain innate anti-inflammatory mechanisms. The tricarboxylic acid cycle-derived metabolite itaconate is highly upregulated in activated macrophages and has been shown to act as an immunomodulator with anti-inflammatory and antimicrobial functions. Mesaconate, an isomer of itaconate, similarly reduces the inflammatory response in macrophages. Nevertheless, most studies have focused on its esterified forms and its peripheral effects, while its influence on the CNS remained largely unexplored. Therefore, this study investigated the immunomodulatory and therapeutic potential of endogenously synthesized itaconate and its isomer mesaconate in lipopolysaccharide (LPS)-induced neuroinflammatory processes. Our results show that both itaconate and mesaconate reduce LPS-induced neuroinflammation, as evidenced by lower levels of inflammatory mediators, reduced microglial reactivity and a rescue of synaptic plasticity, the cellular correlate of learning and memory processes in the brain. Overall, this study emphasizes that both itaconate and mesaconate have therapeutic potential for neuroinflammatory processes in the brain and are of remarkable importance due to their endogenous origin and production, which usually leads to high tolerance.
This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either azithromycin prophylaxis or to placebo. All participants will receive standard of care preoperative antibiotics. The primary objective is to evaluate in patients undergoing scheduled/prelabor cesarean if pre-incision adjunctive azithromycin prophylaxis reduces the risk of post-cesarean infections compared with placebo. Secondary objectives include 1) to assess the perinatal and maternal safety of pre-incision adjunctive azithromycin, 2) to evaluate whether adjunctive azithromycin prophylaxis reduces maternal and neonatal resource use outcomes compared with placebo, and 3) to evaluate whether adjunctive azithromycin influences maternal and neonatal infection with resistant organisms compared with placebo.

Individuals will be randomized prior to the start of the cesarean to either 500mg of intravenous azithromycin or to placebo (normal saline). Maternal blood and cord blood will be collected on a subset of the population. Research staff will abstract maternal and neonatal outcomes following delivery and discharge from the hospital. A single maternal follow-up study visit at 6 weeks (4-8 weeks) postpartum will be scheduled to ascertain maternal and neonatal outcomes.
PROBLEM TO BE SOLVED: To obtain an external preparation for skin which contains an extract from a specific plant, shows excellent elastase-inhibitory action and can prevent skin from aging. SOLUTION: This external preparation for skin contains one or more of extracts from plants growing in Indonesia, Seprantu and Sdemo diluwih. The amount of the extract is 0.0005-20wt.%, preferably 0.001-10wt.% on the dry basis. The extract is obtained by soaking or extracting leaves, stems, flowers, barks, seeds, fruits or the whole plant body in or with an organic solvent under reflux with heat, filtering the extract solution followed by concentration through solvent evaporation. The extract is prepared in ointment, cream, milk emulsion, lotion, pack or bath medicine. This cosmetic suppresses the activity of elastase to restore or maintain the tension and the elasticity of the skin whereby the skin is prevented from aging and kept youthful.
Introduction: Brucellosis, which is among the endemic regions of Turkey, is a common zoonotic disease. The gold standard in diagnosing brucellosis is culture. We aimed to compare demographic characteristics, risk factors, and clinical and laboratory variables between cases with culture positivity and undetected in culture. Materials and Methods: This single-center study was conducted between January 2007 and April 2022. Clinical and laboratory data of patients with brucella growth in blood culture and patients without growth were compared. Results: A total of 150 patients were included in the study. The median age was 10 (1-18 years). Of the patients, 66 (44%) were female and 84 (56%) were male. Forty (26.7%) of the patients were bacteremic and 110 (73.3%) were nonbacteremic. In the bacteremic group, white blood cell count, platelet, and hemoglobin counts were lower, and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) values were higher. In clinical evaluation, fever, hepatomegaly, splenomegaly, and abdominal pain were more common in the bacteremic group. Conclusion: The distinction between bacteremic and nonbacteremic brucellosis can be predicted using laboratory values such as white blood cells, hemoglobin counts, platelet, ALT, and AST, and clinical findings such as fever, abdominal pain, hepatomegaly, and splenomegaly.
Among the various physiological signals, electrocardiogram (ECG) is a valid criterion for the classification of various exercise fatigue. In this study, we combine features extracted by deep neural networks with linear features from ECG and heart rate variability (HRV) for exercise fatigue classification. First, the ECG signals are converted into 2-D images by using the short-term Fourier transform (STFT), and image features are extracted by the visual geometry group (VGG) . The extracted image and linear features of ECG and HRV are sent to the different types of classifiers to distinguish distinct exercise fatigue level. To validate performance, the proposed methods are tested on (i) an open-source EPHNOGRAM dataset and (ii) a self-collected dataset (n = 51). The results reveal that the classification based on the concatenated features has the highest accuracy, and the calculation time of the system is also significantly reduced. This demonstrates that the proposed novel hybrid approach can be used to assist in improving the accuracy and timeliness of exercise fatigue classification in a real-time exercise environment. The experimental results show that the proposed method outperforms other recent state-of-the-art methods in terms of accuracy 96.90%, sensitivity 96.90%, F1-score of 0.9687 in EPHNOGRAM and accuracy 92.17%, sensitivity 92.63%, F1-score of 0.9213 in self-collected dataset.
This invention relates to a system for self treatment. The system consists of several portable modules where one of the modules is designated as a master module. The master module controls, supervises and monitors all the mutual information and data exchange between itself and the rest of the modules. The modules can e.g. consist of a BGM, a doser, an inhaler, a tablet dispenser and a storage container.  The modules may be able to generate and store data which is transmitted to the master module if it is within range and active. If the master module is not within range, the data is kept locally in the module until the master module is available or a new master module is designated. The master module or another specific module can send the data to an external unit like a computer or database for further processing. A physician or an expert care-team can access the data in the database and give guidance to the patient on the basis of these processed data. This processing could also be done automatically by utilization of an expert system.
BACKGROUND AND AIMS: The role of aortic mineralization in the pathogenesis of acute type B aortic dissection (TBAD) is unclear. Whether thoracic aortic calcification (TAC) and circulating alkaline phosphatase (ALP) activity are associated with acute TBAD risk remains elusive.
METHODS: Observational and Mendelian randomization (MR) studies were conducted sequentially. Using propensity score matching (1:1) by age and sex, patients with acute TBAD (n = 125) were compared with control patients (n = 125). Qualitative (score) and quantitative (volume) analyses of the TAC burden on different thoracic aortic segments were conducted using non-enhanced computed tomography. Univariate and multivariate analyses were used to identify significant independent risk factors for TBAD and TAC burden, respectively. MR was finally used to determine the causal relationship between elevated ALP activity and TBAD risk.
RESULTS: The qualitative and quantitative analyses revealed that TAC burden was significantly higher in the TBAD group, except for in the ascending aortic segment (both p < 0.05). Preoperative circulating ALP was significantly elevated in the TBAD group (p < 0.001). The elevated TAC burden score on the descending thoracic aortic segment (odds ratio [OR] 3.31, 95% confidence interval [CI] 1.31-8.37) and increased ALP activity (OR 1.03, 95% CI 1.01-1.06) was independently associated with TBAD risk. Interestingly, ALP was significantly positively associated with TAC burden, and MR analyses confirmed that ALP genetically predicted TBAD risk.
CONCLUSIONS: Elevated ALP may trigger TBAD risk via the increased volume of TAC. Aortic mineralization may not protect the aorta itself.
New capsules for the treatment of diabetes are produced as follows (2.5 pound) is brought to the boil. Kalmi sushura (2.5 pounds) is added. After boiling a further 7.5 mins., Bhung (1 kg) is stirred in, and the mass boiled a further 10 mins, then removed from the fire and cooled by pouring water over it. The cooled mass is converted into powder by passing through an open meshc loth. (suitability of the powder for further processing is checked by sprinkling into a glass of water; if the powder floats, it is suitable for use). After storing underground in a sealed bottle for 40 days, the powder is encapsulated by conventional procedures to give capsules each contg. 1 mg powder. Used in treatment of any stage fo diabetes. The capsules gives a 100% cure, and continued treatment is not necessary provided that aident is followed which involves (a) avoiding eating plants that grow under the ground and (b) ingesting about 1 spoonful of sugar per day.
Tetanus is a life-threatening, vaccine-preventable disease caused by an endotoxin produced by Clostridium tetani. We report a case of severe tetanus in an adult male with a history of intravenous drug use. The patient presented with a 1-day history of inability to open his jaw and a right lower extremity necrotic wound. Initial management consisted of tetanus toxoid, human tetanus immunoglobulin, antimicrobials and intermittent lorazepam. Due to progressive symptoms, wound debridement and placement of an advanced airway in the operating room ensued. Episodes of tetany were associated with fever, autonomic instability, acute desaturations and preemptive ventilator triggering despite maximum doses of continuous propofol and midazolam. Neuromuscular blockade with cisatracurium was added, resulting in control of tetany. Despite initial control, NMB could not be weaned due to recurrent spasms. Intravenous dantrolene was therefore sought as an alternative antispasmodic. Following an initial load, patient was successfully liberated from cisatracurium. Dantrolene was therefore converted to enteral to facilitate gradual down-titration of intravenous sedatives with subsequent conversion to oral benzodiazepines. After a prolonged hospital course, the patient was able to be discharged home. Dantrolene was thus effectively utilized as an adjunctive antispasmodic agent to facilitate liberation from cisatracurium and continuous sedation.
A modified immune cell that has attenuated expression and/or activity of YTH N6-Methyladenosine RNA Binding Protein 2 (YTHDF2), and enhanced anti-tumor activity. A composition for stimulating T cell-mediated immune response to a cancer cell and/or a tumor antigen, including an agent capable of attenuating the expression and/or activity of YTHDF2, and a pharmaceutically acceptable excipient. A composition for treating cancer, comprising an agent capable of attenuating the expression and/or activity of YTHDF2. A method for activating an immune cell. A method for generating an immune cell. A method for treating a disease, disorder or condition associated with an expression of a tumor antigen in a subject in need thereof. A method for stimulating a T cell-mediated immune response to a cancer cell and/or a tumor antigen in a subject in need thereof.